Educated Patient® Multiple Myeloma Summit

How a Plasma Cell Disorder Called MGUS Can Progress to Multiple Myeloma

May 13th 2021, 9:00pm


All patients with multiple myeloma have had MGUS, so what is it?

How Treating Myeloma is About Extending Remissions and Making it ‘Livable’

April 12th 2021, 3:00pm


In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center discusses how she changed her perspective on finding a cure for myeloma and what her goals are when it comes to treating her patients.

Taking a Look Back at CURE®’s Educated Patient® Multiple Myeloma Summit

April 11th 2021, 3:00pm


CURE® is looking back at the Educated Patient® Multiple Myeloma Summit, a half-day virtual event to educate, inform and connect patients with multiple myeloma to a variety of experts in the field.

Myeloma Therapies Create an ‘Optimistic Picture’ for Patients’ Futures

April 6th 2021, 9:00pm


In an interview, Dr. Andrew Yee of Massachusetts General Hospital discusses how a multiple myeloma diagnosis affects a patient’s life and how hopeful he is about helping them lead normal lives.

What It’s Like to Be a Myeloma Millennial, Or, ‘Myelennial’

April 5th 2021, 9:00pm


In an interview, Dr. Nina Shah of UCSF Helen Diller Family Comprehensive Cancer Center explains what a myeloma millennial, or ‘myelennial,’ is, and how recent advances in multiple myeloma treatments inspired the term.

Treatments for Multiple Myeloma Are Transforming Lives

April 1st 2021, 9:00pm


The biggest fear for many patients, according to an expert from The University of Texas MD Anderson Cancer Center, is when they hear that myeloma, for most patients, is not curable. However, she notes that every few years patient survival is increasing.

‘Knowledge Is Power’ When Learning About Treatments for Late Relapsed/Refractory Multiple Myeloma

March 31st 2021, 1:00pm


An expert discusses therapies that are changing the treatment landscape and the research to make this disease more livable.

Spotlighting New and Emerging Therapies in Myeloma

March 24th 2021, 9:00pm


There is a lot of hype on T-cell engagers and CAR T-cell therapy, but there are other new and exciting immunotherapies in myeloma not talked about that may be approved in the near future, according to an expert.

Multiple Myeloma 101: An Incurable But ‘Very Treatable’ Disease

March 22nd 2021, 3:00pm


Although a multiple myeloma diagnosis can be overwhelming for patients, an expert from the Massachusetts General Hospital Cancer Center notes how the disease is very treatable, and that patients can go on to lead full lives.

Assessing Unique Patient Characteristics Critical in Deciding Therapy Options for Early Relapse Myeloma

March 18th 2021, 1:00pm


An expert discusses the treatment options that patients with early relapse myeloma have to treat their recurrent disease, which often follows a cyclical pattern.